| 注册
首页|期刊导航|中国临床药理学杂志|苯磺酸左氨氯地平/富马酸比索洛尔固定复方治疗轻中度原发性高血压的剂量探索:一项多中心、随机、双盲、Ⅱ期临床试验

苯磺酸左氨氯地平/富马酸比索洛尔固定复方治疗轻中度原发性高血压的剂量探索:一项多中心、随机、双盲、Ⅱ期临床试验

陈源源 孙宁玲 刘凤江 屈艳玲 田立 刘莹 陈贝健 杨志星 杨新春

中国临床药理学杂志2026,Vol.42Issue(6):751-758,8.
中国临床药理学杂志2026,Vol.42Issue(6):751-758,8.DOI:10.13699/j.cnki.1001-6821.2026.06.001

苯磺酸左氨氯地平/富马酸比索洛尔固定复方治疗轻中度原发性高血压的剂量探索:一项多中心、随机、双盲、Ⅱ期临床试验

Dose-finding study of amlodipine besilate/bisoprolol fumarate fixed-dose combination in the treatment of mild to moderate essential hypertension:A multicenter,randomized,double-blind,phase Ⅱ clinical trial

陈源源 1孙宁玲 1刘凤江 2屈艳玲 3田立 4刘莹 5陈贝健 6杨志星 7杨新春8

作者信息

  • 1. 北京大学人民医院,北京 100044
  • 2. 施慧达药业集团有限公司,吉林吉林市 134300
  • 3. 运城市中心医院,山西运城 044099
  • 4. 河北医科大学第一医院,河北石家庄 050000
  • 5. 辽宁省人民医院,辽宁沈阳 110016
  • 6. 菏泽市立医院,山东菏泽 274006
  • 7. 山西省心血管病医院,太原 030024
  • 8. 首都医科大学附属北京朝阳医院,北京 100161
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy and safety of different dose combinations of levamlodipine besilate tablets and bisoprolol fumarate tablets compared with placebo and control.Methods A multicenter,randomized,double-blind,double-dummy,placebo-positive drug-controlled dose-finding study in which patients with grade 1-2 essential hypertension were randomly divided into 5 groups after 14 days of placebo,namely:group A(placebo group),group B(levamlodipine besilate 2.5 mg/placebo),group C(bisoprolol 5 mg/placebo),group D(levamlodipine besilate 2.5 mg/bisoprolol fumarate 2.5 mg group)and E group(levamlodipine besilate 2.5 mg/bisoprolol fumarate 5 mg group),treated for 56 days.14 days,28 days,and 56 days after treatment,the main indicators-diastolic blood pressure,and the secondary indicators-systolic blood pressure,were analyzed,and the efficacy and safety were analyzed.Results After 56 days of treatment,the decrease in diastolic blood pressure was 3.26±8.09 mmHg in group A,8.89±6.97 mmHg in group B,7.89±6.48 mmHg in group C,12.64±6.49 mmHg in group D,and 13.46±7.80 mmHg in group E.Compared with group A,groups B,C,D,and E,P<0.001;the reduction of blood pressure between groups D and E(combination treatment group)and group B and C(monotherapy group)was significantly lower than that of group A P<0.01,and P>0.05 between combination treatment groups(D and E)and monotherapy groups(B and C groups).In terms of reducing systolic blood pressure,group B(decrease of 13.39±11.48 mmHg),group D(decrease of 17.55±10.31 mmHg)and group E(decrease of 20.60±13.06 mmHg)and group A(decrease of 5.55±13.19 mmHg)were P<0.001;group E compared with group B and C,P<0.001;compared between group D and C,P<0.01;and P>0.05 between groups D and E of the two combination treatment groups.Conclusion The 2.5 mg levamlodipine besilatee tablets combined with 2.5 mg bisoprolol fumarate tablets and 2.5 mg levamlodipine besilate tablets combined with 5 mg bisoprolol fumarate tablets have good efficacy and are better than the single agent levamlodipine besilate or bisoprolol fumarate in reducing diastolic blood pressure,and are well tolerated.

关键词

原发性高血压/随机、双盲、安慰剂对照/血压降低幅度/安全性

Key words

essential hypertension/randomized/double-blind/placebo-controlled/blood pressure reduction/safety

分类

医药卫生

引用本文复制引用

陈源源,孙宁玲,刘凤江,屈艳玲,田立,刘莹,陈贝健,杨志星,杨新春..苯磺酸左氨氯地平/富马酸比索洛尔固定复方治疗轻中度原发性高血压的剂量探索:一项多中心、随机、双盲、Ⅱ期临床试验[J].中国临床药理学杂志,2026,42(6):751-758,8.

中国临床药理学杂志

1001-6821

访问量1
|
下载量0
段落导航相关论文